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Antibodies to individually specific antigenic determinants (idiotypes) of
immunoglobulins are generally raised in animals that differ genetically from the
individual that produces the immunoglobulin (Ig) used as immunogen : i.e .
heteroantisera (1) and alloantisera (2), from xenogeneic and allogeneic animals
respectively, are the usual sources of anti-idiotypec antibodies (Abs) .' More
recently it has been shown that anti-idiotypes can also be raised in syngeneic
animals : BALB/c mice produced Abs to idiotypes of some myeloma proteins of
BALB/c origin (3-6), and A/J mice produced anti-idiotypes to antistreptococcal
Abs from other A/J mice (7) .
Isologous anti-idiotypes (produced in the syngeneic strain) have been particularly
interesting because they imply that an individual might be capable of forming Abs to
idiotypes of some of his own Igs ; and it has, indeed, been recently demonstrated that a
rabbit can produce Abs against the idiotypes of other Abs made previously in the same
animal (8) . However, attempts to raise Abs to idiotypes of isologous Igs seem not to have
been uniformly successful (5, 6, 9, 10), and we have therefore attempted in this study to
explore further whether most or only exceptional Igs are able to elicit these Abs . BALB/c
mice were immunized with five myeloma proteins of BALB/c origin : four were IgA,
u-proteins with antiphosphorylcholine activity (T15, M167, M603, and M511), and one
was an IgG2a,«-protein with no known ligand (LPC-1) . Anti-idiotypes were clearly
produced to all but one . Tolerance probably accounts for the ineffectiveness of the
exceptional protein, T15, whose idiotype has turned out to be remarkably abundant in
mice (11, 12) . Nevertheless, prolonged immunization with T15 finally induced formation of
isoantibodies ; most of these Abs had a peculiar specificity (they seemed broadly specific
for BALB/c IgA myeloma proteins, especially those with rc-light-chains), but some may
have been specific for the T15 idiotype .
Materials and Methods
Tumors . MOPC-167, MOPC-603, MOPC-511, and TEPC-15 were obtained from M . Potter,
National Cancer Institute, Bethesda, Md . or from Litton Bionetics, Silver Spring, Md . They were
*This study was supported in part by a research grant (CA-15472) and a grant tothe Massachusetts
Institute ofTechnology Center for Cancer Research (CA-14051) from the National Cancer Institute,
National Institutes of Health, Bethesda, Md . ; additional support was provided by the James and
Lynelle Holden Fund .
'Abbreviations used in this paper : Abs, antibodies ; BSA, bovine serum albumin ; PBS, phos-
phate-buffered saline (0.015M NaCl-0 .01 M K phosphate, pH 7.4) .
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maintained by serial passage as subcutaneous or intraperitoneal (ascites) tumors in BALB/cAnN or
BALB/cJ mice. These tumors arose in purebred BALB/cAnN (13).
Myeloma Proteins .
￿
M167, M603, M511, and T15 were isolated from serum or ascites fluid of
tumor-bearing mice, as described (14). After precipitation with half-saturated ammonium sulfate,
the proteins were subjected to mild reduction (0.01 M dithiothreitol in 0.2 M Tris, pH 8.2) andalkyla-
tion (with iodoacetamide), and were then adsorbed on phosphorylcholine-Sepharose 4B, from which
they were specifically eluted with 1 mM phosphorylcholine in phosphate-buffered saline, 0.015 M
NaCl-0.01 M K phosphate, pH 7.4 (PBS). The eluted proteins were concentrated by precipitation
with half-saturated ammonium sulfate, dialyzed against 10 mM K phosphate, pH 7 .4, and finally
freeze-dried. LPC-1, purified by electrophoresis on agarose, was generously provided by C. Janeway,
Jr., National Institute for Allergy andInfectious Diseases, Bethesda, Md.; the tumor producing this
protein also arose in a purebred BALB/cAnN mouse (13) .
Immunization.
￿
As described (3), mice of both sexes were given five (sometimes more) weekly
injections of purified myeloma protein in hind foot pads andseveral (usually four) subcutaneous sites.
Protein was incorporated in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.) for the
first injection, in incomplete Freund's adjuvant (Difco Laboratories) for the second, and in PBS for
the remainder. With T15, booster injections of the protein in the complete adjuvant were repeated at
approximately monthly intervals after thefirst course of five weekly injections (see below) . Generally,
atotal of 200jig protein wasgiven at each injection; but as little as 10,ug canbe effective with some of
these proteins (unpublished observation) .
Forsome trial immunizations, glutaraldehyde wasused to aggregate purified T15or to coaggregate
it with keyhole limpet hemocyanin, or human serum albumin, or M315. Theaggregation wascarried
out with 0.025% glutaraldehyde in PBS, pH 7.0 (15) . In special instances, other immunization
programs were adopted (see Table IV) .
Assay for Anti-Idiotypes .
￿
Adouble Ab radioimmunoassay wasused. Typically, 5 AI of antiserum,
10 pl of 1261-labeled myeloma protein (0.1 ug), and 100 fcl PBS-bovine serum albumin (BSA) were
incubated for 20 min at room temperature, and this wasfollowed by 100 jul of diluted goat antiserum
to mouse Igs (corresponding to 25 pl antiserum anddiluted by Sepharose absorption, see below). After
1 h at 37°C and about 18 h at 4°C, the immune precipitates were washed twice in the cold with
PBS-BSA and counted in a Packard gamma spectrometer (Packard Instrument Co., Inc., Downers
Grove, Ill.) . When dissolved in 1.0 ml of 0.5% sodium dodecyl sulfate, representative precipitates had
an absorbancy of 0.2 (at 278 nm). The goat antiserum to mouse Igs was routinely adsorbed with the
myeloma proteins used as labeled antigen in the assay (usually by passing 5ml antiserum over 2 ml
Sepharose 4B (packed volume] containing about 6 mg myeloma protein).
For inhibition assays, various inhibitors (unlabeled purified myeloma proteins, or whole mouse
serum, or 10 mM phosphorylcholine in PBS) were added to anti-idiotypc serum; then, after 20 min,
the '261-labeled antigen was added and the rest of the assay was as described above.
Mice.
￿
BALB/cJ, CE/J, and A/J were obtained from Jackson Laboratories, Bar Harbor, Maine;
A/Sn and BALB/cAnN were provided by Dr. Ralph Graff, Washington University, St. Louis, Mo.;
BAB/14 and C.ALB were generously furnished by Dr. Roy Riblet, Salk Institute, La Jolla, Calif.;
(BALB/cJ x A/J)F1 hybrids were raised in our laboratory.
Iodination. Myeloma proteins were labeled with carrier-free 12 61 according to the method of
Sonada and Schlamowitz (16). Sp act were usually about 3 x 108 cpm/jug; for assays whose object
was detection of the T15 idiotype in normal sera, the sp act was 3 x 10' cpm/Ag.
Other Procedures and Reagents.
￿
Proteins were dinitrophenylated and numbers of attached DNP
groups per protein molecule were determined as described (17) . Ovalbumin, twice recrystallized hen's
ovalbumin, and keyhole limpet hemocyanin were obtained from Schwarz/Mann Div., Becton,
Dickinson & Co., Orangeburg, N.Y .
Results
Responses to immunization with the four antiphosphorylcholine Igs are
summarized in Table I. Abs to M167, M603, and M511 were detected by 2-3 wk,
but Abs to T15 were not detected until aboosterinjection (in complete adjuvant)
was given 1 mo after the final (fifth) injection of the first course. To determine if
the Abs were anti-idiotypes, various unlabeled Igs were tested for ability toNOBUO SAKATO AND HERMAN N . EISEN
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TABLE I
Response ofBALB/c Mice to Immunization with Phosphorylcholine-Binding Myeloma
Proteins (a.K) ofBALBIc Origin
*Response measured with the "6I-labeled myeloma protein used as immunogen. A response three
times above background (control with normal BALB/c serum) was taken as positive . Values in
parentheses give the range in percent of `261-labeled protein precipitated by positive sera from
individual mice . All mice injected with T15andwith M511 were BALB/cAnN; of the mice injected
with M167,9were of theAnNand10 of theJ subline . Of the mice injected with M603, 9 were of the
AnNand 15 of the J subline. Background was deducted from values in parentheses .
$ 2 wk after the fifth injection .
§3 wk after the fifth injection .
~~ An approximately 1-mo interval separated injections five and six, and injections six and seven .
Injections six and seven were made with T15 in complete Freund's adjuvant .
inhibit the reaction between 125I-labeled immunogen and the corresponding
antisera . As is shown in Fig . 1, the reaction in each case was completely blocked
by the immunogen . Cross-reacting inhibition by other IgA,rc-myeloma proteins
was negligible with anti-M167 and anti-M603, but was pronounced with
anti-M511 .
Antisera to T15 were different : they were no more effectively inhibited by the
immunogen than by the three other a,u-antiphosphorylcholine proteins or by
M460 (also a,K), which binds DNP, TNP, and vitamin K9 (18) but not
phosphorylcholine . M315, an a,X2-protein whose ligand-binding specificities are
similar to those ofM460 (19), inhibited less well ; and LPC-1, a y2a,u-protein with
no known ligands, did not inhibit at all . It appears, therefore, that most of the
anti-T15 molecules were specific forIgA proteins in general, especially those with
x-light-chains (Fig . 1) . However, the reactions of these sera with T15 were not
inhibited by Fab fragments from T15 or the other antiphosphorylcholine
proteins, suggesting that the specific determinants are localized in the Fc domain
of IgA molecules, but are somehow influenced by the molecule's light chain.
In an alternative approach, specificity was evaluated by comparing the
reactivity of the antisera with the labeled immunogen and with other labeled
IgA,K-proteins . This procedurewas less satisfactory than the inhibition assay (see
above), because various labeled protein preparations were probably denatured to
different extents . Nevertheless, the results of the two assays were generally in
Immunogen
2
Proportion of mice
3 4
responding 1
5
wk after
5t
injection
5§
number* :
611 711
T15 0/5 0/15 0/15 - - - 5/10 15/20
(9-34) (4-71)
M167 9/9 19/19 18/18 9/9 8/8 9/9
(20-42) (51-89) (20-81) (59-78) (61-70) (62-69)
M603 4/9 14/24 18/24 5/9 5/9 5/9
(5-7) (7-40) (6-48) (6-37) (10-38) (8-40)
M511 1/10 3/10 3/9 4/9 5/9 4/8
(6) (4-9) (5-9) (10-22) (6-25) (7-26)1414
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FIG . 1 .
￿
Specificity of BALB/c antisera to four BALB/c myeloma proteins . Each quadrant
shows the inhibitory activity of various myeloma proteins (listed with their symbols in A) for
radioimmunoassay reactionsbetween antisera andthe corresponding "'I-labeled immunogen .
Sera in A, C, and D were from BALB/cAnN; serum in B was from BALB/cJ . (A)
Approximately 0.1 ug of ["6I]M167 plus 5 ug of pooled antisera to M167 (obtained 1 wk after
the second immunizing injection with M167) . In the uninhibited control, 44% of the added
["SI]M167 was precipitated, and 80% of this amount was inhibitable by 3mM phosphorylcho-
line (final concentration) . (B) Approximately 0.1 ug [" 5I]M603 plus 5 Ail of pooled, positive
antisera to M603 (obtained 1 wk after the third injection of M603) . In the uninhibited control
20% of the added [111I]M603 was precipitated, and 65% of this amount was inhibitable by 3
mM phosphorylcholine. (C) Approximately0.1 ug [' 11I]M511 plus 5 Al pooled, positive antisera
to M511 (obtained 1 wk after the fifth injection of M511) . In the uninhibited control 16% of
[111I]M511 was precipitated, of which 26% was inhibitable with 3mM phosphorylcholine . (D)
Approximately 0.1 ug [' 2'I]T15 plus 5 ul pooled, positive antisera to T15 (obtained 10 days
after the second booster injection of T15 ; see Table Iand Fig . 2) . In the uninhibited control35%
of the T15 was precipitated, of which <10% was inhibitable by 3 mM phosphorylcholine .
agreement. For instance, as is shown by the representative results of Table II,
anti-M167 and anti-M603 discriminated sharply between the respective im-
munogens (M167 and M603) and the other myeloma proteins, while anti-M511
was less discriminating, and anti-T15 discriminated poorly, if at all (e.g ., it
reacted as well with [125I]M511 as with [111I]T15) .
Phosphorylcholine, which is bound specifically by M167, M603, M511, andT15
(20), extensively inhibited the reactions of M167, M603, and M511 with their
respective antisera, but it inhibited only slightly one of the two anti-T15 sera
(Table III) . It should be noted that inhibition by phosphorylcholine diminished
progressively in successive bleedings ofmice immunized with M167 . Whetherthe
decrease is due to an increase in serum concentration of anti-idiotypes, or to an
increase in their affinity for the idiotype, or to a change in their specificity
remains to be determined .
We conclude from these results (Fig . 1 and Tables II and III) that the BALB/c
Abs to M167 and to M603 were almost exclusively anti-idiotypes, and those to
M511 were largely anti-idiotypes. However, the BALB/c Abs to T15, which* Values are the percent of added '25I-labeled protein (ca. 0.1 ug) that precipitated with 5 ul of im-
mune serum. Values in bold face were obtained with labeled immunogen. Generally 1-3% of 121I_
labeled protein was precipitated with normal mouse serum, used as a control of each assay. Values
less than 10% (three times control) are of dubious significance. The mice injected with T15 and
M511 were BALB/c AnN; those given M167 and M603 were BALB/cJ. Background (normal mouse
serum controls) was deducted from the values shown.
tN, 10 days after booster injection (no. 7, Table I) .
formed only after exceptionally intensive immunization, were specific for IgA
proteins (especially with u-chains) rather than the idiotype of T15 ; a small
proportion of the anti-T15 molecules may, however, have been specific for the
idiotype of T15 (see inhibition by phosphorylcholine, line 16, Table III) .
To induce a distinct anti-idiotyppc response to T15 a variety of additional
immunization procedures were explored. Glutaraldehyde was used to aggregate
T15, with and without various "carrier" proteins. As is shown in Fig. 2,
aggregated T15 was no more immunogenic in BALB/c mice than monodisperse
T15, but coaggregates with BSA, M315, and especially with hemocyanin,
induced earlier formation of anti-T15 Abs. However, these Abs resembled in
specificity those formed after prolonged immunization with monodisperse T15 :
they discriminated poorly, if at all, between T15 and other antiphosphorylcholine
a,rc-proteins (Fig. 3) . That some Abs may have been formed to the idiotype ofT15
was, however, indicated by marginal inhibition with 3 mM phosphorylcholine:
with 10 serum samples from BALB/cJ mice bled 1 wk after the third to fifth
injections of T15-hemocyanin, the inhibition was 8 .4 t 5.7 (mean f standard
deviation) . Fralker et al. (6) have recently also observed that attachment of other
carrier proteins (various Igs) augments the immunogenicity of another BALB/c
myeloma protein (LPC-1, see below) for BALB/c mice .
We also applied to T15 the procedure used by Janeway and Paul (5) to raise
BALB/c Abs to the idiotype of LPC-1, a 72a,ß-myeloma protein of BALB/c
origin . In this procedure, which is based on the earlier work of Iverson (10),
alum-precipitated, lightly dinitrophenylated myeloma protein (about 2 DNP
groups/150,000 daltons) was injected into mice that had been previously
immunized with DNP-hemocyanin . As is shown in Table IV, the effectiveness of
this procedure for LPC-1 was confirmed, but it failed to elicit Abs to T15 .
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TABLE II
Specificity of Isologous (BALBIc) Anti-Idiotypes*
1415
'25I-labeledproteins
Bleeding after Immunogen injection no:
M167 M603 M511 T15 M315 M460
T15 Nt 33 39 71 62 21
M167 2 54 12 10 0 4 4
3 65 13 14 2 6 8
M603 3 0 30 0 0 0 0
M511 5 2 8 14 2 - 3
7 4 13 19 5 - 71416
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TABLE III
Hapten Inhibition of the Reaction between Myeloma Proteins and the Respective
Isologous Anti-Idiotypes
* I, Weekly injections of immunogen : first in complete Freunds adjuvant ; second in incomplete
adjuvant ; third, fourth, and fifth in PBS (see Materials and Methods) . II, Same as I, but first
injection in incomplete adjuvant . III, first injection, immunogenadsorbed on precipitated alum and
injected intraperitoneally (i.p .) 4 h after an i.p . injection of 2 x 10° B. pertussis organisms. Second
injection, immunogen injected i.p . in PBS.
$Final ligand concentration, 3 mM . Values are mean 1 standard deviation for the number of
individual animals listed in extreme right-hand column .
§3 wk after first immunization (with alum ppQ
114 wk after first immunization (1 wk after second injection, in PBS, i.p .) .
Ti 5 wk after first immunization (2 wk after second injection) .
** Pooled antiserum.
$$ N-1, 10 days after first booster injection ; N-2, 10 days aftersecond booster injection . (For intervals,
see Table I and Fig . 1 .)
To explore the basis for the poor immunogenicity of the T15 idiotype in
BALB/c mice, the responses to T15 were examined in some other strains and in
some hybrids . The results are summarized in Table V, and specificities of the
resulting antisera are illustrated in Fig . 4. The responses of hybrid (BALB/cJ x
A/J)F, mice were only slightly better (if at all) than those of purebred BALB/c,
but all the other strains responded well . The responses of A/J, A/Sn (not shown),
and CE/J mice were similar : some Abs in their early bleedings were probably
specific for allotypes of BALB/c a-chains (see inhibition by M315 and M460 in
Figs . 4A and C) . Other Abs made in these strains were specific for T15: though
Immunogen Strain
Immunization
schedule*
Bleeding
after
injection
no . :
Inhibition
by phosphoryl-
choline$
No . of
Mice
M167 BALB/cAnN 1 2 76.0 1 4.1 9
I 3 52 .9 1 21.6 9
I 4 41 .2 1 17.1 8
M167 BALB/cJ 1 3 68.7120.1 10
I 4 45.81 10.2 8
II 2 88.6 1 4.0 5
II 3 72.6 1 23 .8 5
II 4 40.4 1 25 .6 5
III 1§ 86.1 1 10 .2 6
III 211 68.3 1 11 .5 6
M603 BALB/cJ 1 34 27.7123.2 8
1 4 29 .4 1 29.9 11
M511 BALB/cAnN I 5 27.3** 4
I 6 30.2** 5
I 7 28.8** 4
T15 BALB/cAnN I N-1$$ 17.714 .7 3
I N-2$$ 3.8 1 5.0 7100
0
a
U
a 50
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FIG . 2 . Increased immunogenicity of aggregated T15 . The injected protein was either
unaggregated (715 monomer,") or aggregated via glutaraldehyde with itself (715-715 poly-
mer, O) or ith M315, or hemocyanin, or human serum albumin (HSA) . See Table I for time
intervals beyond 5 wk (withT15and T15-715 aggregate) . Each symbol represents the bleeding
of an individual BALB/cAnN mouse .
T15-M315 TI5 "Hemocyonin T15-HSA
(-)T15-715
-1
15 25
fug . Inhibitor Added
FIG. 3 .
￿
Specificity of the BALB/c antisera produced by immunization with aggregated T15
(see Fig . 2) . The myeloma proteins used as inhibitors are listed with symbols in A. Each test
used approximately 0.1 ug ["'I]T15 and5 ul antiserum (pooled, positive sera) . The proportion
of added ["'I]715 that precipitated in uninhibited controls was19% in A, 63% in B, and71% in
C. There was no significant inhibition by 3mM phosphorylcholine. (A) Sera obtained 1 wk
after third injection of T15-HSA . (B) Sera obtained 1 wk after third injection of T15-
hemocyanin . (C) Sera obtained 1 wk after fifth injection of T15-hemocyanin .1418
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TABLE IV
Induction of Isologous Anti-Idiotypic Antibodies to LPC-1 but not to T15 by Injecting
DNP-Proteins into DNP-Primed Mice
* 100Ag of protein in complete Freund's adjuvant was injected (primary) into hind foot pads . 10 days
later the mice were injected (secondary) with 100 FAg of protein in alum-precipitated form 4 hafter
2 x 10 9 B. pertussis organisms were injected i.p . 21 days afterwards the mice were injected i.p . with
the same protein as in the secondary injection, but in PBS .
$Antibody to T15was measured by radioimmunoassay (see MaterialsandMethods), using [ ...I]T15 .
Antibody to LPC-1 was measured by Farr assay using 0.3 Ag of 1251-labeled Fab fragment of LPC-1
and 10 tit antiserum (5); values are means (percent added antigen bound) for individual bleedings
from the number of mice shown in parentheses . 0 means <5%. Normal mouse serum (background)
values were deducted from the tabulated entries .
§ 21 days after secondary injection .
T 12 days after third injection .
they were just as readily inhibited by M511 as by T15, they clearly distinguished
these from other a,a-antiphosphorylcholine proteins (M167 and M603), and the
discrimination was especially pronounced in late bleedings (Figs . 4 B and D) .
In the BAB/14 congenic strain' the genome is BALB/c except forgenes of the Ig
heavy chain linkage group, which are derived from C57BL/6 (21) . About half the
Abs made against T15 in BAB/14 were readily inhibited by M315 andM460 and
appear, therefore, to be specific for allotypes of BALB/c a-chains (Figs. 4 E and
F) . Other anti-T15 Abs made in BAB/14 resembled in specificity the anti-T15
molecules formed in BALB/c, the isologous strain : they did not distinguish T15
from the other antiphosphorylcholine proteins (Figs . 4 E and F) .
The congenic C.AL9 strain' also has the BALB/c genome, but its genes for the
Ig heavy chain linkage group are derived from theAL strain (21) . The anti-T15
Abs made in one C.AL9 mouse cross-reacted extensively with other a,ic-proteins
(Fig . 4 G) ; but in a second mouse of this strain some of the anti-T15 molecules
s BAB/14 mice were developed by Dr . Leonard Herzenberg (Stanford University, Stanford, Calif.)
from backcross mice provided by Dr . Michael Potter, National Cancer Institute : after aBALB/cAnN
x C57BL/Ka cross and 14 successive backcrosses to BALB/cAnN, homozygosity was established for
the C57BL/Ka IgC  allotype (21) and maintained by brother-sister matings . A similar procedure
established the C.AL, line : after a cross ofBALB/cAnN x AL and nine successive back-crosses to
BALB/cAnN, homozygosity wasestablished for the AL IgC  allotype (21) and maintained by brother-
sister matings .
Primary
Immunization*
Secondary
Antigen
1st bleeding§
bound$
2ndbleeding T
OVA T15 0(5) 0(5)
OVA DNP.-T15 0(5) 0(5)
DNA.-OVA T15 0(5) 0(5)
DNP.-OVA DNP.-T15 0(5) 0(5)
KLH DNP.-T15 0(5) 0(5)
DNP,-KLH DNP.-Tl5 0(5) 0(5)
DNP.-OVA DNP,-LPC-1 29(3) 400
DNP,-KLH DNP,-LPC-1 25(2) 52(2)Strain
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TABLE V
Production of Antibodies to T15 in Mice of Various Strains
Proportion of mice responding after injection number* :
A/J
￿
9/9
￿
8/8
￿
8/8
￿
8/8
(40.1 t 23.7)
￿
(77.6 f6.6)
￿
(88.2 t 2.1)
￿
(73 .6 t 5.2)
A/Sn
￿
10/10 10/10 10/10 10/10
(50.1 f 17.2)
￿
(84.1 t 1.3)
￿
(86.7 t 2 .4)
￿
(66.4 t 4.0)
CE/J
￿
10/10 10/10 9/9 10/10
(58.9 t 9.0)
￿
(85.1 t 5.9)
￿
(76.7 t 0.7)
￿
(78.5 t 2.4)
(A x BALB/c)F,
￿
0/7
￿
1/7
￿
5/7
￿
5/7
(8 .6)
￿
(10.2 t 4.7)
￿
(11 .3 t 5.0)
BAB/14
￿
3/4 4/4 4/4 4/4
(11.3 f 7.9)
￿
(27.4 f 17.8)
￿
(55.1 t 16.8)
￿
(59 .7 t 12.9)
C.ALs ￿5/5
￿
5/5
￿
5/5
￿
5/5
(10.2 t 10.0)
￿
(35.9 t 14.2)
￿
(49.3 t 15.2)
￿
(54.8 t 18.8)
*Weekly injections as in Materials andMethods (i .e ., thesame as schedule I of Table III) . Responses
were measured by radioimmunoassay with ["°I]T15. A response three times above background
(1-3% of the ["'I ]T15 precipitated with normal BALB/c serum) was taken as positive . Values in
parentheses are mean t standard deviation for percent ["'IIT15 precipitated by positive sera from
individual mice. Background was deducted from values in parentheses .
resembled the anti-idiotypes made in AandCE strains : i.e ., they distinguished
T15 from M167 but not from M511 (Fig . 4 H) .
To account for the variety of responses to T15, the level of this idiotype in
serum from normal mice of various strains was estimated with a radioimmune
inhibition assay, whose specificity and sensitivity are shown in Fig . 5. The
antisera for this assay were produced in A/J and CE/J mice and absorbed with
M460 (a,a) : though specific for T15 the adsorbed sera did not distinguish it from
M511 . Despite the resulting ambiguity, the natural prevalence of the T15 (M511)
idiotype seems pretty clearly to be inversely correlated with ability to produce
Abs against this idiotype : these Abs were not produced by mice that normally
contain the T15 idiotype (BALB/c, A/J x BALB/cJ hybrids, and BAB/14),
whereas they were readily formed by strains in which the idiotype is just at or
below the level of detection (A/J and CE/J) . However, in one of two CAL, mice
the Abs appeared to be relatively specific for T15 (compare Fig . 4 H with Figs . 4
A and C), and yet normal serum from CAL, mice contains this (or the M511)
idiotype . The apparent inconsistency could be due to inability of the key
antiserum to distinguish between T15 and M511 (Fig . 5) . Similar lack of absolute
specificity might also account for disagreements in the literature regarding the
presence (22) or absence (11) of the T15 idiotype in serum of C57BL/6 mice .1420
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FIG. 4.
￿
Specificity of antisera raised in various mouse strains to T15. Approximately 0.1 lAg
T15 and 5 u1 antiserum was used in each assay (for inhibition assay see Assay for
Anti-Idiotypes, Materials and Methods) . (A andB) Pooled sera from A/Jmice bled 1wk after
thesecond (A) or the third (B) injection . (C andD) Pooled sera from CE/J mice bled 1wk after
the second (C) or fifth (D) injection . (E and F) Pooled sera from BAB/14 mice bled 1 wk after
thethird (E) or fourth (F) injection . (G and H) Individual sera from twoCAL.mice bled 1wk
after the fourth injection .
Discussion
The four myeloma proteins on whichthis report is focussed-T15, M167, M603
and M511-are similar in structure, function, andgenetic background (13) . They
are all a,rc-proteins of BALB/c origin ; they bind phosphorylcholine and precipi-
tate specifically with a heteropolymeric pneumococcal polysaccharide ; from
partial amino acid sequences it appears that three of them (T15, M603, and
M511) have the identical sequence fortheir heavy (a) chains from theNterminus
through the first hypervariable region (positions 1-35), and that the heavy chain
of the fourth (M167) differs from these only by valine in place of leucine atNOBUO SAKATO AND HERMAN N . EISEN
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FIG. 5 .
￿
Specificity and sensitivity of the radioimmunoassay used to measure serum levels of
proteins with the T15 (M511) idiotype . The complete reaction (0.125 ml) contained 0.01 lag
["'I]T15, 0.025 jA1 antiserum to T15, obtained from A/Sn mice (1 wk after the third injection of
T15 and absorbed with M460), 1 to 10 dal of test material (normal serum from various strains or
purified myeloma proteins), and sufficient normal A/J serum to bring the total mouse serum to
10 ;,1 (to provide mouse Ig for the goat antiserum) . After incubation, T15-absorbed goat
antiserum to mouse Ig was added .
position four (reference 23 and footnote 3) . Their light (K) chains, however, differ
considerably in sequence (reference 23 and footnote 3) and the proteins also differ
in idiotype and in immunogenicity for isologous (BALB/c) mice .
In ability to induce the formation of isologous antiidiotypic Abs, the order is
M167 > M603 > M511 > T15 (Table I) . The same order applies to the
specificity of the resulting isoantibodies . The inhibition studies of Fig. 1 (all with
unabsorbed sera) show that the BALB/c Abs raised against M167 reacted only
with this protein, and that the Abs produced against M603 were almost as
selective in their reaction with M603 . Antisera raised against M511 reacted best
with this protein, butthey also cross-reacted extensively with othera,rc-proteins .
In contrast to the other antiphosphorylcholine proteins, Abs were produced to
T15 only after unusually prolonged immunization of BALB/c mice, and they
seemed largely to be specific fora-chains in general, particularlywhen associated
with a-light-chains (Fig . 1 D) . These anti-T15 molecules probably represent an
autoimmune response evoked by exceptionally intense immunization . It would
be of interest to determine whether there are pathologic changes in mice that
make this response (e.g . renal lesions from immune complexes ; reference 24) .
It must be emphasized that all the isoantisera used here (except in the assay of
Fig . 5 and Table VI) were not absorbed . Hence they probably represent an
unbiased reflection of the specificities of B cells in normal BALB/c mice . These
mice evidently possessB cells that can recognize and respond to the idiotypes of
many BALB/c Igs . This has been demonstrated here for three myeloma proteins
(M167, M603, and M511), and in previous studies with three others (M315 and
M460, reference3; LPC-1, references 5 and6; and confirmed in Table IV) .B cells
with specificity forthe idiotypes of isologous Igs are not confined to BALB/c mice
The partial amino acid sequences of heavy and light chains of T15, M603, and M167 are in
reference 23 ; the corresponding sequences of M511 are from E . Appella (personal communication) .1422
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TABLE VI
Concentration of the T15 (M511) Idiotype in Normal Serum from Mice of Various
Strains*
*The assay system : 0.025 1al A/J anti-T15 serum, 10 ng ['z5I]T15 (about 20,000 cpm), 1-10 gal
serumfrom normal mice of the indicated strain anda sufficient volume of normal A/Jserum to bring
total vol of normal mouse serum to 10 g1, sufficient excess of goat-antimouse Ig (absorbed with T15)
to precipitate all the Ig in 10,1 of normal mouse serum. To test for the T15 idiotype in normal A/J
serum, normal and anti-T15 serum of the CE/J strain was used .
f Serum from BALB/cJ mice bled 2 wk after immunization with pneumococcal vaccine (0 .1 ml, 2 x
101 organisms injected i.p .) .
and their myeloma proteins : A/J mice can produce anti-idiotypes to Abs raised
by immunizing other A/J mice with a streptococcal vaccine (7) .
Why isologous anti-idiotypes to BALB/c myeloma proteins have not been
elicitable in some studies (e.g ., 9) is not clear . The idiotypes of the Igs tested
might have been almost as prevalent as that of T15 (see below) ; another
possibility is that the relatively insensitive precipitin assay was used to detect
idiotype to anti-idiotype reactions (9) . Whatever the reason, it now seems clear
that the Igs capable of eliciting formation of isologous anti-idiotypes are not
exceptional ; it is possible that almost any Ig can be made to stimulate the
production of these Abs.
T15 appears so far to be unusual . Of the seven myeloma proteins tested in this
laboratory, it alone failed to elicit distinct anti-idiotypes in isologous (BALB/c)
mice when administered by procedures or with adjuvants that are effective with
the other proteins (i.e ., the use of complete Freund's adjuvant, or injection of the
protein as a coaggregate with various "carrier" proteins, or as a lightly
dinitrophenylated molecule adsorbed on alum and given to mice that were
previously injected with Bordetella pertussis and primed to make anti-DNP
antibodies) . The unresponsiveness to the idiotype could be due to tolerance,
resulting from the prevalence of this idiotype in normal BALB/c mice . It seems
that virtually all the antiphosphorylcholine Abs made in this strain share theT15
idiotype : thus, injection of a specific anti-T15 serum (produced in A/He mice)
into newborn BALB/c suppresses their ability, later in life, to make antiphos-
phorylcholine Abs (in response, for instance, to immunization with a pneumococ-
cal vaccine [25]) . Moreover, this idiotype is extraordinarily abundant in serum of
BALB/c mice, even without deliberate immunization (reference 11 and Table
Strain Amount of serum tested Inhibition
T15/milliliter
serum
Al % kg-equivalents
BALB/cJ 5 52 4
A/J 10 <5 <0 .1
(BALB/c x A)F, 10 72 3
AKR/J 10 <5 <0 .1
CE/J 10 16 0.4
C57BL/6J 10 64 3
BAB/14 1 50 13
CAL. 10 65 2
BALB/cJt 1 60 24NOBUO SAKATO AND HERMAN N . EISEN
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VI) : with a total serum Ig level in unimmunized BALB/c of, say, 5 mg Ig/ml
serum (probably much less) the finding of 5,g Ig/ml with this idiotype (Table VI ;
or higher level, reference 11) means that over 1/1,000 Ig molecules of normal
BALB/c have this idiotype .
An alternative explanation for BALB/c unresponsiveness to the T15 idiotype is
that these animals lack a required immune response gene (26) . Responsiveness
should then be dominant, and (BALB/c x A)F1 hybrids should resemble
purebred A/J, i.e ., they should form anti-idiotypes to T15 . Instead, like purebred
BALB/c, these hybrids are not responsive to this idiotype, which is also readily
detected in their normal serum .
It thus seems clear that the inability ofBALB/c mice to form anti-idiotypes to
T15 is due to tolerance, resulting from the natural abundance of this idiotype in
this strain . Though the ensuing depletion (or inactivity) of anti-T15 B cells is
likely to be extensive, a few active cells probably persist in some animals. This
would account for the finding that phosphorylcholine inhibits slightly (but
probably significantly) the reaction between T15 and a few of the BALB/c
antisera to T15 (obtained after prolonged immunization with monomer T15 or
after briefer immunization with T15-hemocyanin coaggregates) .
It is generally believed that each myeloma protein represents one of the many
Igs that make up the immensely heterogenous pool of normal Igs . However, with
a sensitive hemagglutination-inhibition assay Kunkel has shown that in pooled
human Ig the respective idiotypes of several myeloma proteins are present at less
than 1 part in 1-30 million, if at all (27) . A similarly low frequency of BALB/c
myeloma proteins in normal BALB/c mice would probably account for their lack
of tolerance and the regularity with which they can make anti-idiotype responses
to many of .these proteins . What concentrations of idiotypes, or of other
indigenous proteins, are required to establish and maintain naturalself-tolerance
is still not clear . These critical levels can, perhaps, be eventually determined by
correlating in individual mice the serum level of certain idiotypes, such as T15,
with the capacity to form the corresponding anti-idiotype .
It seems not to have been generally expected that BALB/c mice would be able
to form Abs to idiotypes of BALB/c myeloma proteins, perhaps because this
seems at first glance to contradict the role of "associative recognition" in the
induction of Ab formation . According to this concept (28), an immunogenically
effective myeloma protein should contain, in addition to its idiotype, other
determinants to which the responding animal is not tolerant . It has been
suggested that allotypes can serve as the other determinants, and that the only
mice able to form anti -idiotypic Abs to mouse Igs would be those that lack both
idiotype and allotype of the immunogen (9) . In support of this idea, attachment
of IgG from C57BL/6 mice (whose heavy chain allotypes differ from those of
BALB/c) to LPC-1, aBALB/c IgG2a myeloma protein, was particularly effective
in augmenting BALB/c Ab response to the idiotype of LPC-1 (6) . Allotypic
disparity probably also contibuted to the immunogenicity ofT15 in BAB/14 and
C.AL,, mice (Fig . 4) : these congenic BALB/c animals lack the heavy chain
allotypes of purebred BALB/c (instead, they have the heavy chain allotypes of
the C57BL/6 and AL strains, respectively), and they could thus respond
effectively to the BALB/c heavy chain allotype on T15 . Nonetheless, the present1424
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results reinforce earlier evidence (3-5) that allotypic discordance is not essential
for stimulating the production of Abs to isologous idiotypes.
Since members of an inbred strain can form Abs to idiotypes of Igs from other
members of the same strain, it is not surprising that a given individual can
produce anti-idiotypes to some of his own Abs (8) . The consequences for the Ig
repertoire are significant : an individual can form Abs not only to a vast number
of different antigens, but also to the combiningsites ofsome (or perhaps many) of
these Abs . Anti-idiotypes, moreover, must have their own idiotypes, with which
other isologous or autochthonous Igs (anti-anti-idiotypes) might react, etc . This
could mean that the number of Igs an individual can make is virtually limitless,
or that individual Ig molecules can bind many different antigens (29,30) . A
number of recent findings provide some evidence for multispecificity of Abs
(31-36) .
Jerne has proposed that many Igs are "natural" anti-idiotypes, capable of
reacting specifically with the combining sites of other Igs, and that through
reaction with appropriate B cells these anti-idiotypes might regulate the
production of Igs with the corresponding idiotypes (37) . The possibility that
anti-idiotypes might serve as physiological regulators of Ig production by B cells
is supported by the consistency with which mice are able to form Absto idiotypes
of Igs from syngeneic animals, and by the additional finding, to be reported
elsewhere, that thymus-derived lymphocytes can also recognize idiotypes of
isologous Igs .' Though these capabilities have so far been prominently expressed
only after intensive immunization, it has recently been reported that autologous
anti-idiotypes can be formed spontaneously against Abs that arise in the course
of a conventional immune response (38) . It is also possible, however, that instead
of stimulating the production of autologous anti-idiotypes, a rising level of Ab
might serve as a tolerogen, inducing specific unresponsiveness to its idiotype
(39) .
Summary
To determine if the immunoglobulins (Igs) capable of eliciting the formation
of isologous anti-idiotypec antibodies are rare exceptions, BALB/c mice were
immunized with five myeloma proteins of BALB/c origin . Anti-idiotypes were
produced against all but one . The idiotype of the exception (T15) is remarkably
abundant in BALB/c mice, whose unresponsiveness is probably due to tolerance.
Nevertheless, prolonged immunization with T15 finally induced the formation of
isologous antibodies that seemed largely to be specific for IgA proteins, especially
those with a-light-chains ; the reactions of a few of these isologous antisera with
T15 were slightly inhibited by phosphorylcholine, suggesting that some anti-idi-
otypes were probably formed even to this unusually prevalent idiotype . It is likely
that under appropriate conditions almost any myeloma protein can elicit
isologous anti-idiotypes .
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